NCT07133542Completed
Multicomponent Weight Management Versus Structured Aerobic Exercise in Postgraduate Students
Adaptive Weight Management Guided by a 3×3 WC-BFP Phenotype in Postgraduate Students With Overweight or Obesity: An Exploratory Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 23 Oct 2026
Brief summary (registry, in English)
This single-center, two-arm, parallel exploratory randomized controlled trial compared multicomponent weight management incorporating a 3×3 waist circumference-body fat percentage (WC-BFP) phenotype classification with structured aerobic exercise over 8 weeks. Forty-eight postgraduate students with overweight, central obesity, or elevated BFP were randomized 1:1. The adaptive intervention combined aerobic, resistance, and flexibility exercise with individualized nutritional and behavioral support; WC and BFP were reassessed every 2 weeks to guide prescription adjustments. The comparator involved 3-5 aerobic exercise sessions per week, with a prescribed weekly aerobic-duration target exceeding 150 minutes per week, with progressive intensity from 40%-50% to 60%-80% of heart rate reserve. Both groups received individualized daily energy-intake targets intended to create an energy deficit, wearable monitoring, online exercise and dietary logging, and remote supervision. Anthropometric outcomes and exercise self-efficacy were assessed at baseline and weeks 4 and 8; exercise adherence was assessed at weeks 4 and 8. The trial evaluated the intervention packages as a whole and did not isolate the independent contribution of WC-BFP classification. The manuscript emphasizes week-8 body weight, with additional anthropometric, behavioral, and exploratory classification outcomes. The trial was retrospectively registered; subsequent record updates do not establish prospective specification of the outcome hierarchy.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 48 (actual)
- First submitted
- 10 Aug 2025
- Start date
- 20 Apr 2025
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Hainan Normal University
- Diseases
- Obesity
- NCT number
- NCT07133542
What you commit to
- Study type: Interventional
- Participants enrolled: 48
- From 20 Apr 2025 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Confounding Medications: Use of weight/metabolism-affecting drugs in past 3 months.
- Conflicting Participation: Concurrent enrollment in other weight-management trials.
Other illness
- Metabolic Diseases: Diagnosed diabetes, thyroid dysfunction, or history of cardiovascular disease.
- Exercise Contraindications: Orthopedic/neurological conditions limiting exercise.
Other
- Special Physiological Status:Pregnancy or lactation.
Who the study is looking for
- Age \& Status:Full-time postgraduate students aged 18-36 years.
- Excess-Adiposity Criteria:
- Meeting at least one of the following criteria:
- Overweight or obesity (BMI \> 24 kg/m2);
- Central obesity (WC \> 85 cm in men or \> 80 cm in women);High BFP (\> 20% in men or \> 25% in women).
- Exercise Capacity: Able to safely perform moderate-intensity exercise (confirmed by PhysicalActivity Readiness Questionnaire \[PAR-Q\], all items "No").
- Tech Compliance: Own smartphone with proficiency in health apps (e.g., WeChat Sport).
- Informed Consent: Signed written informed consent before study participation.
Age in the registry: 18 years to 36 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hainan Normal University Coordinator of this site? Confirm its status | Haikou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.